Antibiotic resistance: Cameron warns of medical 'dark ages'


David Cameron: "We are in danger of going back to the dark ages of medicine"

Related Stories

The world could soon be "cast back into the dark ages of medicine" unless action is taken to tackle the growing threat of resistance to antibiotics, Prime Minister David Cameron has said.

He has announced a review into why so few anti-microbial drugs have been introduced in recent years.

Economist Jim O'Neill will lead a panel including experts from science, finance, industry, and global health.

It will set out plans for encouraging the development of new antibiotics.

'Taking the lead'

The prime minister said: "If we fail to act, we are looking at an almost unthinkable scenario where antibiotics no longer work and we are cast back into the dark ages of medicine where treatable infections and injuries will kill once again."

Mr Cameron said he discussed the issue at a G7 leaders meeting in Brussels earlier this month and got specific support from US President Barack Obama and German Chancellor Angela Merkel.

It is hoped that the review panel's proposals will be discussed at next year's G7 summit, which will be hosted by Germany.

"Penicillin was a great British invention by Alexander Fleming back in 1928," Mr Cameron told the BBC. "It's good that Britain is taking the lead on this issue to solve what could otherwise be a really serious global health problem."

He said the panel would analyse three key issues: the increase in drug-resistant strains of bacteria, the "market failure" which has seen no new classes of antibiotics for more than 25 years, and the over-use of antibiotics globally.

'Time bomb'

It is estimated that drug-resistant strains of bacteria are responsible for 5,000 deaths a year in the UK and 25,000 deaths a year in Europe.

bacteria A resistant strain of bacteria

Chief Medical Officer for England Prof Dame Sally Davies has been a key figure helping to get the issue on the government and global agenda.

Last year she described the threat of antimicrobial resistance as a "ticking time bomb" and said the dangers it posed should be ranked along with terrorism.

She spoke at a meeting of scientists at the Royal Society last month which warned that a response was needed akin to efforts to combat climate change.

Dame Sally said: "I am delighted to see the prime minister taking a global lead by commissioning this review.

"New antibiotics made by the biotech and pharmaceutical industry will be central to resolving this crisis which will impact on all areas of modern medicine."

Antibiotics dates of discovery timeline

Medical research charity the Wellcome Trust is providing £500,000 of funding for Mr O'Neill and his team, which will be based at their headquarters in central London.

Antimicrobial resistance has been a key issue for Jeremy Farrar, since he became director of the Wellcome Trust last year.

"Drug-resistant bacteria, viruses and parasites are driving a global health crisis," he said.

"It threatens not only our ability to treat deadly infections, but almost every aspect of modern medicine: from cancer treatment to Caesarean sections, therapies that save thousands of lives every day rely on antibiotics that could soon be lost."

'Market failure'

Antibiotics have been an incredible success story, but bacteria eventually develop resistance through mutation.

One example is MRSA, which has been a major threat for years in hospitals. It is resistant to all but the most powerful of antibiotics, and the main weapon against it is improved hygiene, which cuts the opportunity for infection to spread.

Without antibiotics a whole raft of surgical procedures would be imperilled, from hip replacements to cancer chemotherapy and organ transplants.

Before antibiotics, many women died after childbirth after developing a simple bacterial infection.

Mr O'Neill is a high-profile economist who is best-known for coining the terms Bric and Mint - acronyms to describe countries which are emerging and potential powerhouses of the world economy.

He is not, though an expert on antibiotics or microbes. But Mr Cameron told the BBC it was important to have an economist heading the review:

"There is a market failure; the pharmaceutical industry hasn't been developing new classes of antibiotics, so we need to create incentives."

Jeremy Farrar said: "This is not just a scientific and medical challenge, but an economic and social one too which would require analysis of regulatory systems and behavioural changes to solve them."

Mr O'Neill will begin work in September and is expected to deliver his recommendations next spring.

Last month antibiotic resistance was selected as the focus for the £10m Longitude Prize, set up to tackle a major challenge of our time.

Fergus Walsh Article written by Fergus Walsh Fergus Walsh Medical correspondent

Defeating cancer, the 'evil genius'

Can we win the war against cancer? Over the past 18 months, Panorama has followed a group of patients on drug trials. Some who'd been given months to live, are keeping cancer at bay for years.

Read full article

More on This Story

Related Stories

The BBC is not responsible for the content of external Internet sites


This entry is now closed for comments

Jump to comments pagination
  • rate this

    Comment number 1559.

    This may have already been suggested however, Dame Sally answered a question re the use of natural products that are a possible source, the answer given, there is no scientific evidence to support this claim, my point is this why not use some of this 10 million to carry out the required testing? Cynically of me do bear in mind natural products cannot be patented so no profit so maybe no research.

  • rate this

    Comment number 1558.

    I haven't seen or heard any mention of bacteriophages in the recent coverage of antibacterial resistance.
    Why has there not been more coverage of their use as an alternative route to tackling general resistance? Phages have already been found to tackle e.g. Listeria and MRSA. It would need some effort to commercialise the application of phages, but they could tackle the resistant strains.

  • rate this

    Comment number 1557.

    Sustainable medicine concept in all aspect of human, animal and environment treatment has to be adopted. Stop reckless antibiotics use to compensate for lack of good practice and adopt safe waste disposal from antibiotic administered patients. Likewise, let us explore natural bioactive compounds that can replace or potentiate antibiotics use, at least find all options to overcome resistance.

  • rate this

    Comment number 1556.

    I worked many years as a practice nurse in the NHS and I can tell you that patient compliance and education is one of the things which has led to anti biotic resistance. Patients do not even now realise their responsibility to finish the course of anti microbials, or if they need them at all. Rushed GPs often cave in to pressure from those who feel they MUST have an anti biotic for every malady

  • rate this

    Comment number 1555.

    Simple-big pharma makes its billions by developing drugs to fight illnesses caused by side affects of other drugs they make that fight side affects .....

    Cause of Antibiotic resistance may also be caused by doctors prescribing multiple prescriptions for a weak cheap dose of antibiotic when a single strong one is needed (why give up all those return visits)


Comments 5 of 1559



Copyright © 2015 BBC. The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.